Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Endothelium-dependent relaxation is resistant to inhibition of nitric oxide synthesis, but sensitive to blockade of calcium-activated potassium channels in essential hypertension

Abstract

In human essential hypertension (EH), endothelium-dependent relaxation can occur independent of nitric oxide (NO) and prostacyclin (PGI2). Recent in vivo data suggest that rapid compensatory upregulation of endothelial cytochrome P450 epoxygenase 2C9 occurs to preserve vasorelaxation under conditions of decreased NO bioavailability. As one of the vascular actions of CYP2C9 is to modulate small and intermediate conductance endothelial calcium-activated potassium channels (SKCa and IKCa), we examined whether endothelium-dependent relaxation is sensitive to inhibitors of these channels (apamin and charybdotoxin) in resistance-sized vessels from human with EH. Subcutaneous gluteal biopsies were performed on 12 humans with EH and 12 matched control subjects. Resistance arteries were dissected and relaxation responses to carbachol were assessed ex vivo using wire myography in the presence of: (i) NG-nitro-L-arginine (L-NOARG)/indomethacin; and (ii) apamin/charybdotoxin. Maximal carbachol relaxation was impaired in EH vs control subjects. No differences in responses were observed with the endothelium-independent agonist, S-nitroso-N-acetyl-penicillamine. Relaxation to carbachol was attenuated following incubation with L-NOARG/indomethacin in vessels from control subjects (P<0.01 analysis of variance (ANOVA)), but not in vessels from patients with EH. The reverse pattern was seen following apamin/charybdotoxin with carbachol relaxation attenuated only in EH vessels (P<0.001 ANOVA). Endothelium-dependent relaxation is resistant to endothelial nitric oxide synthase inhibition but sensitive to blockade of calcium-activated potassium channels in human EH. Studies with more specific inhibitors are required to determine whether this response is mediated by endothelial potassium channel subtypes (SKCa and IKCa).

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3

Similar content being viewed by others

Abbreviations

BKCa:

large conductance calcium-activated potassium channels

COX:

cyclooxygenase

CYP2C9:

cytochrome P450 epoxygenase 2C9

EDHF:

endothelium-derived hyperpolarising factor

eNOS:

endothelial nitric oxide synthase

11,12 EET:

11,12 epoxyeicosatrienoic acids

IKCa:

intermediate conductance calcium-activated potassium channels

NE:

norepinephrine

NO:

nitric oxide

L-NOARG:

NG-nitro-L-arginine

PGI2:

prostacyclin

SKCa:

small conductance calcium-activated potassium channels

SNAP:

S-nitroso-N-acetyl-penicillamine

References

  1. Feletou M, Vanhoutte PM . Endothelial dysfunction: a multifaceted disorder. Am J Physiol 2006; 291: H985–H1002.

    Article  CAS  Google Scholar 

  2. Panza JA, Quyyumi AA, Brush JE, Epstein SE . Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N Engl J Med 1990; 323: 22–27.

    Article  CAS  Google Scholar 

  3. Taddei S, Virdis A, Mattei P, Ghiadoni L, Gennari A, Fasolo C et al. Aging and endothelial function in normotensive subjects and patients with essential hypertension. Circulation 1995; 91: 1981–1987.

    Article  CAS  Google Scholar 

  4. Park JB, Charbonneau F, Schiffrin EL . Correlation of endothelial function in large and small arteries in human essential hypertension. J Hypertens 2001; 19: 415–420.

    Article  CAS  Google Scholar 

  5. Cockcroft JR, Chowienczyk PJ, Benjamin N, Ritter JM . Preserved endothelium-dependent vasodilatation in patients with essential hypertension. N Engl J Med 1994; 330: 1036–1040.

    Article  CAS  Google Scholar 

  6. Schofield I, Malik R, Izzard A Austin C, Heagerty A . Vascular structural and functional changes in type 2 diabetes mellitus: evidence for the roles of abnormal myogenic responsiveness and dyslipidemia. Circulation 2002; 106: 3037–3043.

    Article  Google Scholar 

  7. Taddei S, Ghiadoni L, Virdis A, Buralli S, Salvetti A . Vasodilation to bradykinin is mediated by an ouabain-sensitive pathway as a compensatory mechanism for impaired nitric oxide availability in essential hypertensive patients. Circulation 1999; 100: 1400–1405.

    Article  CAS  Google Scholar 

  8. Halcox JP, Narayanan S, Cramer-Joyce L, Mincemoyer R, Quyyumi AA . Characterization of endothelium-derived hyperpolarizing factor in the human forearm microcirculation. Am J Physiol 2001; 208: H2470–H2477.

    Google Scholar 

  9. Taddei S, Versari D, Cipriano A, Ghiadoni L, Galetta F, Franzoni F et al. Identification of a cytochrome P450 2C9-derived endothelium-derived hyperpolarizing factor in essential hypertensive patients. J Am Coll Cardiol 2006; 48: 508–515.

    Article  CAS  Google Scholar 

  10. Edwards G, Dora KA, Gardener MJ, Garland CJ, Weston AH . K+ is an endothelium-derived hyperpolarizing factor in rat arteries. Nature 1998; 396: 269–272.

    Article  CAS  Google Scholar 

  11. Griffith TM, Chaytor AT, Taylor HJ, Giddings BD, Edwards DH . cAMP facilitates EDHF-type relaxations in conduit arteries by enhancing electrotonic conduction via gap junctions. Proc Natl Acad Sci 2002; 99: 6392–6397.

    Article  CAS  Google Scholar 

  12. Campbell WB, Gebremedhin D, Pratt PF, Harder DR . Identification of epoxyeicosatrienoic acids as endothelium-derived hyperpolarizing factors. Circ Res 1996; 78: 415–423.

    Article  CAS  Google Scholar 

  13. Fisslthaler B, Popp R, Kiss L, Potente M, Harder DR, Fleming I et al. Cytochrome P450 2C is an EDHF synthase in coronary arteries. Nature 1999; 401: 493–497.

    Article  CAS  Google Scholar 

  14. Matoba T, Shimokawa H, Nakashima M, Hirakawa Y, Mukai Y, Hirano K et al. Hydrogen peroxide is an endothelium-derived hyperpolarizing factor in mice. J Clin Invest 2000; 106: 1521–1530.

    Article  CAS  Google Scholar 

  15. Matoba T, Shimokawa H, Kubota H, Morikawa K, Fujiki T, Kunihiro I et al. Hydrogen peroxide is an endothelium-derived hyperpolarizing factor in human mesenteric arteries. Biochem Biophys Res Commun 2002; 290: 909–913.

    Article  CAS  Google Scholar 

  16. Rummery NM, Hill CE . Vascular gap junctions and implications for hypertension. Clin Exp Pharmacol Physiol 2004; 31: 659–667.

    Article  CAS  Google Scholar 

  17. Shimokawa H, Yasutake H, Fujii K, Owada MK, Nakaike R, Fukumoto Y et al. The importance of the hyperpolarizing mechanism increases as the vessel size decreases in endothelium-dependent relaxations in rat mesenteric circulation. J Cardiovasc Pharmacol 1996; 28: 703–711.

    Article  CAS  Google Scholar 

  18. Brandes RP, Schmitz-Winnenthal FH, Félétou M, Gödecke A, Huang PL, Vanhoutte P et al. An endothelium-derived hyperpolarizing factor distinct from NO and prostacyclin is a major endothelium-dependent vasodilator in resistance vessels of wild-type and endothelial NO synthase knockout mice. Proc Natl Acad Sci 2000; 97: 9747–9752.

    Article  CAS  Google Scholar 

  19. Scotland RS, Chauhan S, Vallance PJ, Ahluwalia A . An endothelium-derived hyperpolarizing factor-like factor moderates myogenic constriction of mesenteric resistance arteries in the absence of endothelial nitric oxide synthase-derived nitric oxide. Hypertension 2001; 38: 833–839.

    Article  CAS  Google Scholar 

  20. Félétou M, Vanhoutte PM . Endothelium-derived hyperpolarizing factor: where are we now? Arterioscler Thromb Vac Biol 2006; 26: 1215–1225.

    Article  Google Scholar 

  21. Fleming I, Busse R . Endothelium-derived epoxyeicosatrienoic acids and vascular function. Hypertension 2006; 47: 629–633.

    Article  CAS  Google Scholar 

  22. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003; 42: 1206–1252.

    Article  CAS  Google Scholar 

  23. World Medical Association Declaration of Helsinki. Recommendations guiding physicians in biomedical research involving human subjects. Cardiovasc Res 1997; 35: 2–3.

  24. Aalkjaer C, Pedersen EB, Danielsen H, Fjeldborg O, Jespersen B, Kjaer T et al. Morphological and functional characteristics of isolated resistance vessels in advanced uraemia. Clin Sci 1986; 71: 657–663.

    Article  CAS  Google Scholar 

  25. Mulvany MJ, Harpen W . Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats. Circ Res 1977; 41: 19–26.

    Article  CAS  Google Scholar 

  26. Petrie MC, Padmanabhan N, McDonald JE, Hillier C, Connell JM, McMurray JJ . Angiotensin converting enzyme (ACE) and non-ACE dependent angiotensin II generation in resistance arteries from patients with heart failure and coronary heart disease. J Am Coll Cardiol 2001; 37: 1056–1061.

    Article  CAS  Google Scholar 

  27. Fichtlscherer S, Dimmeler S, Breuer S, Busse R, Zeiher AM, Fleming I . Inhibition of cytochrome P450 2C9 improves endothelium-dependent, nitric oxide-mediated vasodilatation in patients with coronary artery disease. Circulation 2004; 109: 178–183.

    Article  CAS  Google Scholar 

  28. Scotland RS, Madhani M, Chauhan S, Moncada S, Andresen J, Nilsson H et al. Investigation of vascular responses in endothelial nitric oxide synthase/cyclooxygenase-1 double-knockout mice: key role for endothelium-derived hyperpolarizing factor in the regulation of blood pressure in vivo. Circulation 2005; 111: 796–803.

    Article  CAS  Google Scholar 

  29. Thollon C, Fournet-Bourguignon MP, Saboureau D, Lesage L, Reure H, Vanhoutte P et al. Consequences of reduced production of NO on vascular reactivity of porcine coronary arteries after angioplasty: importance of EDHF. Br J Pharmacol 2002; 136: 1153–1161.

    Article  CAS  Google Scholar 

  30. Sainsbury CA, Sattar N, Connell JM, Hillier C, Petrie JR . Non-esterified fatty acids impair endothelium-dependent vasodilation in rat mesenteric resistance vessels. Clin Sci 2004; 107: 625–629.

    Article  CAS  Google Scholar 

  31. Kernohan AFB, Sattar N, Cleland SJ, Small M, Lumsden MA, Connell JMC et al. Low dose continuous combined HRT and vascular function in women with type 2 diabetes. Diab Vasc Dis Res 2004; 1: 82–88.

    Article  Google Scholar 

Download references

Acknowledgements

Dr Sainsbury was supported at the time of this work by a fellowship from the Hypertension Trust of the British Hypertension Society.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to C A R Sainsbury.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sainsbury, C., Coleman, J., Brady, A. et al. Endothelium-dependent relaxation is resistant to inhibition of nitric oxide synthesis, but sensitive to blockade of calcium-activated potassium channels in essential hypertension. J Hum Hypertens 21, 808–814 (2007). https://doi.org/10.1038/sj.jhh.1002226

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.jhh.1002226

Keywords

This article is cited by

Search

Quick links